Cerebras CEO Challenges AI Doomsday Narratives at TechCrunch Disrupt

Image: TechCrunch · Source

Cerebras CEO Andrew Feldman urges a balanced view on AI, emphasizing its benefits alongside risks, and calls for thoughtful regulation and better community engagement by the data center industry.

At TechCrunch Disrupt 2026, Andrew Feldman, CEO and co-founder of AI chipmaker Cerebras Systems, pushed back against the prevailing doomsday narratives surrounding artificial intelligence. Feldman criticized some prominent AI leaders for focusing excessively on apocalyptic risks, suggesting that their public warnings might be counterproductive to the industry’s progress. He remarked that rather than dwelling on fears, AI advocates should highlight the technology’s transformative potential, such as curing diseases like cancer, which could fundamentally change future generations’ lives.

Feldman acknowledged the inherent duality of powerful technologies, noting that with their benefits come inevitable risks, especially if misuse occurs. He advocated for measured regulation and thoughtful management of AI development to mitigate potential dangers without stifling innovation.

Beyond AI’s societal impact, Feldman addressed challenges caused by the data center sector’s expansion in response to AI demand. He pointed out the industry’s struggles in engaging with local communities in the United States, contrasting this with more collaborative approaches observed in countries like Brazil, Canada, and Sweden. This lack of local cooperation has contributed to opposition using "not-in-my-backyard" (NIMBY) sentiments.

Regarding industry competition and efficiency, Feldman expressed confidence that advancements in hardware and model optimization will collectively drive meaningful AI progress, without diminishing demand for Cerebras’ products or those from competitors such as Nvidia. His pragmatic stance underscores the need to balance efficiency improvements with continued growth in the AI sector.

Cerebras’ clients include leading AI-focused organizations like OpenAI and pharmaceutical giant GSK, illustrating the company’s central role in powering AI applications across industries. Feldman’s perspective offers a counterpoint to more alarmist views, calling for optimism and responsible stewardship as AI technologies mature.